Drug information for EMTRICITABINE
Form
Dosage
Status
Therapeutic Equivalence
Active Ingred
Ref.
Sponsor
Document
CAPSULE; ORAL
200MG
Tentative Approval
EMTRICITABINE
emtricitabine
AUROBINDO PHARMA
79188
2008-12-19 Letter
CAPSULE; ORAL
200MG
Tentative Approval
EMTRICITABINE
emtricitabine
MATRIX LABS LTD
90488
2009-01-02 Letter
CAPSULE; ORAL
200MG
Tentative Approval
EMTRICITABINE
emtricitabine
CIPLA LIMITED
91168
2011-04-01 Letter
Drug Adverse Effects information for EMTRICITABINE
Role code
Indications
Reaction
# Reports
SS
ANTIRETROVIRAL THERAPY
DRUG RESISTANCE
15
SS
ANTIRETROVIRAL THERAPY
PSYCHIATRIC SYMPTOM
15
SS
ANTIVIRAL TREATMENT
HEPATITIS C
5
SS
CYTOMEGALOVIRUS CHORIORETINITIS
BLOOD ALKALINE PHOSPHATASE INCREASED
2
SS
CYTOMEGALOVIRUS CHORIORETINITIS
BRONCHOPULMONARY ASPERGILLOSIS
2
SS
CYTOMEGALOVIRUS CHORIORETINITIS
CYTOMEGALOVIRUS CHORIORETINITIS
2
SS
CYTOMEGALOVIRUS CHORIORETINITIS
GAMMA-GLUTAMYLTRANSFERASE INCREASED
2
SS
CYTOMEGALOVIRUS CHORIORETINITIS
LYMPHOMA
2
SS
CYTOMEGALOVIRUS CHORIORETINITIS
PLATELET COUNT DECREASED
2
SS
HIV INFECTION
ABSCESS NECK
3
SS
HIV INFECTION
ARTHRALGIA
6
SS
HIV INFECTION
ARTHRITIS
6
SS
HIV INFECTION
BLOOD ALKALINE PHOSPHATASE INCREASED
12
SS
HIV INFECTION
BLOOD THYROID STIMULATING HORMONE INCREASED
6
SS
HIV INFECTION
BRONCHOPULMONARY ASPERGILLOSIS
12
SS
HIV INFECTION
CD4 LYMPHOCYTES INCREASED
17
SS
HIV INFECTION
CEREBRAL TOXOPLASMOSIS
17
SS
HIV INFECTION
CRYOGLOBULINS PRESENT
6
SS
HIV INFECTION
CYTOMEGALOVIRUS CHORIORETINITIS
12
SS
HIV INFECTION
DEMENTIA
4
SS
HIV INFECTION
DIARRHOEA
20
SS
HIV INFECTION
DRUG RESISTANCE
17
SS
HIV INFECTION
DYSPHONIA
6
SS
HIV INFECTION
EAR INFECTION
17
SS
HIV INFECTION
EPILEPSY
17
SS
HIV INFECTION
FEBRILE CONVULSION
3
SS
HIV INFECTION
GAMMA-GLUTAMYLTRANSFERASE INCREASED
12
SS
HIV INFECTION
GASTROINTESTINAL DISORDER
17
SS
HIV INFECTION
GENERALISED OEDEMA
6
SS
HIV INFECTION
HEPATOTOXICITY
17
SS
HIV INFECTION
HYPERTHYROIDISM
6
SS
HIV INFECTION
HYPOTHYROIDISM
6
SS
HIV INFECTION
IMMUNE RECONSTITUTION SYNDROME
26
SS
HIV INFECTION
KLEBSIELLA INFECTION
3
SS
HIV INFECTION
LETHARGY
6
SS
HIV INFECTION
LYMPHADENITIS BACTERIAL
3
SS
HIV INFECTION
LYMPHOMA
12
SS
HIV INFECTION
MENINGITIS
17
SS
HIV INFECTION
MONOPLEGIA
17
SS
HIV INFECTION
NAUSEA
17
SS
HIV INFECTION
NEOPLASM MALIGNANT
6
SS
HIV INFECTION
OESOPHAGEAL CANDIDIASIS
17
SS
HIV INFECTION
PLATELET COUNT DECREASED
12
SS
HIV INFECTION
PNEUMONIA STREPTOCOCCAL
17
SS
HIV INFECTION
POLYNEUROPATHY
17
SS
HIV INFECTION
PORTAL HYPERTENSION
33
SS
HIV INFECTION
PULMONARY ARTERIAL HYPERTENSION
8
SS
HIV INFECTION
QUADRIPARESIS
17
SS
HIV INFECTION
RENAL FAILURE ACUTE
3
SS
HIV INFECTION
RHABDOMYOLYSIS
3
SS
HIV INFECTION
RHEUMATOID ARTHRITIS
6
SS
HIV INFECTION
RHEUMATOID FACTOR INCREASED
6
SS
HIV INFECTION
SEPSIS
17
SS
HIV INFECTION
SQUAMOUS CELL CARCINOMA OF SKIN
6
SS
HIV INFECTION
SYNOVITIS
6
SS
HIV INFECTION
TREATMENT FAILURE
17
SS
HIV INFECTION
TREATMENT NONCOMPLIANCE
17
SS
HIV INFECTION
VIITH NERVE PARALYSIS
17
SS
HIV INFECTION
VIRAL LOAD INCREASED
17
SS
HIV INFECTION
VIRAL UPPER RESPIRATORY TRACT INFECTION
3
SS
HIV INFECTION
VOMITING
17
SS
HIV INFECTION
WEIGHT INCREASED
6
SS
HIV INFECTION
WOUND
6
SS
OPPORTUNISTIC INFECTION PROPHYLAXIS
BLOOD ALKALINE PHOSPHATASE INCREASED
2
SS
OPPORTUNISTIC INFECTION PROPHYLAXIS
BRONCHOPULMONARY ASPERGILLOSIS
2
SS
OPPORTUNISTIC INFECTION PROPHYLAXIS
CYTOMEGALOVIRUS CHORIORETINITIS
2
SS
OPPORTUNISTIC INFECTION PROPHYLAXIS
GAMMA-GLUTAMYLTRANSFERASE INCREASED
2
SS
OPPORTUNISTIC INFECTION PROPHYLAXIS
LYMPHOMA
2
SS
OPPORTUNISTIC INFECTION PROPHYLAXIS
PLATELET COUNT DECREASED
2
SS
PNEUMONIA STREPTOCOCCAL
CD4 LYMPHOCYTES INCREASED
1
SS
PNEUMONIA STREPTOCOCCAL
CEREBRAL TOXOPLASMOSIS
1
SS
PNEUMONIA STREPTOCOCCAL
DIARRHOEA
1
SS
PNEUMONIA STREPTOCOCCAL
DRUG RESISTANCE
1
SS
PNEUMONIA STREPTOCOCCAL
EAR INFECTION
1
SS
PNEUMONIA STREPTOCOCCAL
EPILEPSY
1
SS
PNEUMONIA STREPTOCOCCAL
GASTROINTESTINAL DISORDER
1
SS
PNEUMONIA STREPTOCOCCAL
HEPATOTOXICITY
1
SS
PNEUMONIA STREPTOCOCCAL
IMMUNE RECONSTITUTION SYNDROME
1
SS
PNEUMONIA STREPTOCOCCAL
MENINGITIS
1
SS
PNEUMONIA STREPTOCOCCAL
MONOPLEGIA
1
SS
PNEUMONIA STREPTOCOCCAL
NAUSEA
1
SS
PNEUMONIA STREPTOCOCCAL
OESOPHAGEAL CANDIDIASIS
1
SS
PNEUMONIA STREPTOCOCCAL
PNEUMONIA STREPTOCOCCAL
1
SS
PNEUMONIA STREPTOCOCCAL
POLYNEUROPATHY
1
SS
PNEUMONIA STREPTOCOCCAL
QUADRIPARESIS
1
SS
PNEUMONIA STREPTOCOCCAL
SEPSIS
1
SS
PNEUMONIA STREPTOCOCCAL
TREATMENT FAILURE
1
SS
PNEUMONIA STREPTOCOCCAL
TREATMENT NONCOMPLIANCE
1
SS
PNEUMONIA STREPTOCOCCAL
VIITH NERVE PARALYSIS
1
SS
PNEUMONIA STREPTOCOCCAL
VIRAL LOAD INCREASED
1
SS
PNEUMONIA STREPTOCOCCAL
VOMITING
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
DIARRHOEA
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
RENAL FAILURE ACUTE
1
SS
PRODUCT USED FOR UNKNOWN INDICATION
RHABDOMYOLYSIS
1
C
ANTIBIOTIC PROPHYLAXIS
DIALYSIS
2
C
ANTIBIOTIC PROPHYLAXIS
RENAL FAILURE
6
C
ANTIFUNGAL PROPHYLAXIS
DIALYSIS
1
C
ANTIFUNGAL PROPHYLAXIS
RENAL FAILURE
3
C
ANTIRETROVIRAL THERAPY
BACTERIAL SEPSIS
4
C
ANTIRETROVIRAL THERAPY
NEUTROPENIA
4
C
ANTIVIRAL PROPHYLAXIS
BURKITT'S LYMPHOMA
3
C
ANTIVIRAL PROPHYLAXIS
CEREBRAL TOXOPLASMOSIS
3
C
ANTIVIRAL PROPHYLAXIS
NEOPLASM RECURRENCE
3
C
ANTIVIRAL PROPHYLAXIS
OFF LABEL USE
3
C
ANTIVIRAL PROPHYLAXIS
URINARY RETENTION
3
C
ANTIVIRAL TREATMENT
RENAL TUBULAR ACIDOSIS
4
C
BURKITT'S LYMPHOMA
BURKITT'S LYMPHOMA
11
C
BURKITT'S LYMPHOMA
CEREBRAL TOXOPLASMOSIS
11
C
BURKITT'S LYMPHOMA
NEOPLASM RECURRENCE
11
C
BURKITT'S LYMPHOMA
OFF LABEL USE
11
C
BURKITT'S LYMPHOMA
URINARY RETENTION
11
C
FEBRILE NEUTROPENIA
BACTERIAL SEPSIS
6
C
FEBRILE NEUTROPENIA
NEUTROPENIA
6
C
HEPATITIS C
HYPERBILIRUBINAEMIA
24
C
HEPATITIS C
RENAL FAILURE
24
C
HIV INFECTION
ACIDOSIS
3
C
HIV INFECTION
BASAL CELL CARCINOMA
2
C
HIV INFECTION
BLOOD CREATININE INCREASED
7
C
HIV INFECTION
CIRCULATORY COLLAPSE
9
C
HIV INFECTION
COMA
9
C
HIV INFECTION
CONGENITAL ANOMALY
1
C
HIV INFECTION
DIALYSIS
3
C
HIV INFECTION
DISTRIBUTIVE SHOCK
3
C
HIV INFECTION
DRUG INTERACTION
10
C
HIV INFECTION
DRUG LEVEL INCREASED
7
C
HIV INFECTION
FOETAL EXPOSURE DURING PREGNANCY
1
C
HIV INFECTION
HEART RATE INCREASED
3
C
HIV INFECTION
HYPERBILIRUBINAEMIA
32
C
HIV INFECTION
INTERNATIONAL NORMALISED RATIO DECREASED
3
C
HIV INFECTION
METABOLIC ACIDOSIS
6
C
HIV INFECTION
OVERDOSE
9
C
HIV INFECTION
POLYDACTYLY
1
C
HIV INFECTION
POLYURIA
3
C
HIV INFECTION
RENAL FAILURE
48
C
HIV INFECTION
RENAL IMPAIRMENT
7
C
HIV INFECTION
SHOCK
6
C
HYPERTENSION
BLOOD CREATININE INCREASED
3
C
HYPERTENSION
DRUG INTERACTION
3
C
HYPERTENSION
DRUG LEVEL INCREASED
3
C
HYPERTENSION
RENAL IMPAIRMENT
3
C
LIPIDS INCREASED
BLOOD CREATININE INCREASED
1
C
LIPIDS INCREASED
DRUG INTERACTION
1
C
LIPIDS INCREASED
DRUG LEVEL INCREASED
1
C
LIPIDS INCREASED
RENAL IMPAIRMENT
1
C
MEAN ARTERIAL PRESSURE
CIRCULATORY COLLAPSE
5
C
MEAN ARTERIAL PRESSURE
COMA
5
C
MEAN ARTERIAL PRESSURE
DISTRIBUTIVE SHOCK
5
C
MEAN ARTERIAL PRESSURE
METABOLIC ACIDOSIS
5
C
MEAN ARTERIAL PRESSURE
OVERDOSE
5
C
MEAN ARTERIAL PRESSURE
RENAL FAILURE
5
C
MIGRAINE
BLOOD CREATININE INCREASED
2
C
MIGRAINE
DRUG INTERACTION
2
C
MIGRAINE
DRUG LEVEL INCREASED
2
C
MIGRAINE
RENAL IMPAIRMENT
2
C
MYALGIA
HYPERBILIRUBINAEMIA
8
C
MYALGIA
RENAL FAILURE
8
C
NON-HODGKIN'S LYMPHOMA STAGE IV
BACTERIAL SEPSIS
9
C
NON-HODGKIN'S LYMPHOMA STAGE IV
NEUTROPENIA
9
C
OVERDOSE
ACIDOSIS
1
C
OVERDOSE
CIRCULATORY COLLAPSE
1
C
OVERDOSE
COMA
1
C
OVERDOSE
OVERDOSE
1
C
OVERDOSE
RENAL FAILURE
1
C
OVERDOSE
SHOCK
1
C
PRODUCT USED FOR UNKNOWN INDICATION
BACTERIAL SEPSIS
1
C
PRODUCT USED FOR UNKNOWN INDICATION
BLOOD ALCOHOL INCREASED
2
C
PRODUCT USED FOR UNKNOWN INDICATION
BLOOD CREATININE INCREASED
2
C
PRODUCT USED FOR UNKNOWN INDICATION
CIRCULATORY COLLAPSE
6
C
PRODUCT USED FOR UNKNOWN INDICATION
COMA
6
C
PRODUCT USED FOR UNKNOWN INDICATION
DISTRIBUTIVE SHOCK
1
C
PRODUCT USED FOR UNKNOWN INDICATION
DRUG INTERACTION
2
C
PRODUCT USED FOR UNKNOWN INDICATION
DRUG LEVEL INCREASED
2
C
PRODUCT USED FOR UNKNOWN INDICATION
HEART RATE INCREASED
2
C
PRODUCT USED FOR UNKNOWN INDICATION
METABOLIC ACIDOSIS
6
C
PRODUCT USED FOR UNKNOWN INDICATION
NEUTROPENIA
1
C
PRODUCT USED FOR UNKNOWN INDICATION
OVERDOSE
4
C
PRODUCT USED FOR UNKNOWN INDICATION
POLYURIA
5
C
PRODUCT USED FOR UNKNOWN INDICATION
RENAL FAILURE
8
C
PRODUCT USED FOR UNKNOWN INDICATION
RENAL IMPAIRMENT
2
C
PRODUCT USED FOR UNKNOWN INDICATION
SHOCK
4
C
TAKAYASU'S ARTERITIS
DRUG INTERACTION
1
C
TAKAYASU'S ARTERITIS
INTERNATIONAL NORMALISED RATIO DECREASED
1
C
VITAMIN SUPPLEMENTATION
DIALYSIS
1
C
VITAMIN SUPPLEMENTATION
RENAL FAILURE
3
I
CONTRACEPTION
DRUG INEFFECTIVE
2
I
CONTRACEPTION
DRUG INTERACTION
2
I
CONTRACEPTION
ECTOPIC PREGNANCY
2
I
HIV INFECTION
DRUG INEFFECTIVE
10
I
HIV INFECTION
DRUG INTERACTION
10
I
HIV INFECTION
ECTOPIC PREGNANCY
10
Ads by Google